Role of early circulating tumour cell (CTC) monitoring for prediction of clinical outcome in patients with HER-2 negative metastatic breast cancer receiving first-line treatment with bevacizumab and paclitaxel
No Thumbnail Available
Identifiers
Date
2020-05-01
Authors
Alvarez-Lopez, I.
Gonzalez, E.
Manso, L. M.
Alonso, J. L.
Cruz-Hernandez, J. J.
Caranana Ballerini, V.
Gallegos, I.
Quindos Varela, M.
Illaramendi, J. J.
Vicente, E.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
